Total Payments
$4,333
2024 Payments
$1,257
Companies
20
Transactions
205
Medicare Patients
2,310
Medicare Billing
$138,821
Payment Breakdown by Category
Food & Beverage$3,883 (89.6%)
Education$449.91 (10.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,883 | 199 | 89.6% |
| Education | $449.91 | 6 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,334 | 83 | $0 (2024) |
| Amgen Inc. | $442.17 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $391.08 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $386.17 | 11 | $0 (2024) |
| PFIZER INC. | $336.25 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $216.71 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $174.27 | 8 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $168.00 | 8 | $0 (2024) |
| LEO Pharma Inc. | $148.47 | 8 | $0 (2024) |
| Incyte Corporation | $141.46 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,257 | 64 | ABBVIE INC. ($354.59) |
| 2023 | $1,009 | 41 | ABBVIE INC. ($267.65) |
| 2022 | $1,230 | 56 | ABBVIE INC. ($468.82) |
| 2021 | $836.97 | 44 | AbbVie Inc. ($243.09) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.86 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.49 | General |
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 389 | 605 | $62,190 | $21,907 |
| 2022 | 10 | 555 | 874 | $93,506 | $33,094 |
| 2021 | 10 | 533 | 823 | $81,986 | $32,680 |
| 2020 | 13 | 833 | 1,442 | $120,251 | $51,140 |
Total Patients
2,310
Total Services
3,744
Medicare Billing
$138,821
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 159 | $26,881 | $8,174 | 30.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 63 | 68 | $10,200 | $4,046 | 39.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 35 | 44 | $6,600 | $3,360 | 50.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 62 | 75 | $8,250 | $2,440 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,773 | $1,293 | 34.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 30 | $2,250 | $1,108 | 49.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 43 | 189 | $1,890 | $795.14 | 42.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 22 | $2,346 | $690.71 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 137 | 186 | $32,050 | $9,861 | 30.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 92 | 110 | $16,500 | $6,463 | 39.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 61 | 69 | $10,350 | $4,470 | 43.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 82 | 107 | $11,770 | $3,534 | 30.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $7,442 | $2,602 | 35.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 47 | $5,074 | $1,461 | 28.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 31 | 42 | $3,150 | $1,461 | 46.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 14 | 18 | $3,150 | $1,439 | 45.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 54 | 249 | $2,490 | $1,218 | 48.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $1,530 | $585.69 | 38.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 118 | 133 | $19,950 | $8,511 | 42.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 117 | $17,764 | $6,746 | 38.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 58 | 99 | $7,425 | $3,921 | 52.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 43 | 46 | $6,900 | $3,524 | 51.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 72 | 95 | $10,450 | $3,132 | 30.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 45 | 45 | $8,673 | $2,509 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 18 | $3,783 | $1,441 | 38.1% |
About Catherine Luz, MSN, APRN, FNP-C
Catherine Luz, MSN, APRN, FNP-C is a Family healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1578080651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Catherine Luz, MSN, APRN, FNP-C has received a total of $4,333 in payments from pharmaceutical and medical device companies, with $1,257 received in 2024. These payments were reported across 205 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,883).
As a Medicare-enrolled provider, Luz has provided services to 2,310 Medicare beneficiaries, totaling 3,744 services with total Medicare billing of $138,821. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Riverside, RI
- Active Since 08/29/2017
- Last Updated 06/09/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1578080651
Products in Payments
- SKYRIZI (Biological) $935.63
- TREMFYA (Drug) $370.38
- EUCRISA (Drug) $316.51
- DUPIXENT (Biological) $305.65
- Otezla (Drug) $297.80
- RINVOQ (Biological) $272.10
- OPZELURA (Drug) $141.46
- TALTZ (Drug) $134.62
- ADBRY (Biological) $133.89
- HUMIRA (Biological) $126.42
- Enbrel (Biological) $125.51
- ILUMYA (Biological) $108.85
- Sotyktu (Drug) $94.75
- COSENTYX (Biological) $93.75
- Cabtreo (Drug) $65.67
- JUBLIA (Drug) $63.12
- Bimzelx (Biological) $60.63
- Ilumya (Biological) $42.40
- COSENTYX (Drug) $41.95
- DUOBRII (Drug) $39.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Riverside
Mr. David Ramos, Aprn, APRN
Family — Payments: $10,454
Family $10,454
Michael Josiah
Family — Payments: $6,456
Family $6,456
Ms. Keena Harrison, Fnp-C, FNP-C
Family — Payments: $5,383
Family $5,383
Nicole De Angelis
Family — Payments: $4,895
Family $4,895
Ms. Mayra Rivera, Fnp, FNP
Family — Payments: $4,018
Family $4,018
Hannah Vance, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $3,245
Family $3,245